Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in <b><i>RPE65</i></b>.

Med Genet · 2025 · PMC11812477 · PMID 39943983

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

The results were promising, as the majority of patients experienced a significant increase in visual performance at reduced light levels, indicating improved rod vision, while changes in visual acuity representing cone function did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in &lt;b&gt;&lt;i&gt;RPE65&lt;/i&gt;&lt;/b&gt;.

The sentences

Long-term experience with gene augmentation therapy in patients with inherited retinal disease associated with biallelic mutations in <b><i>RPE65</i></b>.